Jeffrey A. Feinstein, MD, MPH
Academic Appointments
- Associate Professor - Med Center Line, Pediatrics - Cardiology
- Member, Bio-X
- Member, Child Health Research Institute
Key Documents
Contact Information
-
Clinical Offices
Pediatric Heart Center 725 Welch Rd MC 5912 Palo Alto, CA 94304-1601 Tel Work (650) 721-2121 Fax (650) 724-5650Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Overview
Clinical Focus
- Pediatric Cardiology
- Congenital Heart Defects
- Pulmonary Hypertension
- Pulmonary Vascular Disease
- Pulmonary Vascular Abnormalities
Administrative Appointments
- Director, Pediatric Cardiology Inpatient Ward, Stanford University Medical Center (2011 - present)
- Director, Pediatric Cardiology Training Program, Stanford University Medical School (2009 - present)
- Director, Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University Medical Center (2000 - present)
Professional Education
| Board Certification: | Pediatric Cardiology, American Board of Pediatric Cardiology (1998) |
| Fellowship: | Children's Hospital Boston MA (1998) |
| Fellowship: | Children's Hospital National Medical Center DC (1997) |
| Residency: | Children's Hospital National Medical Center DC (1994) |
| MS: | Duke University, Biomedical Engineering (1987) |
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Research interests include (1) computer simulation and modeling of cardiovascular physiology with specific attention paid to congenital heart disease and its treatment, and (2) the evaluation and treatment of pulmonary hypertension/pulmonary vascular disease and structural abnormalities of the pulmonary arteries as seen, for example, in Alagille Syndrome.
In the area of computational modeling, projects are underway in three areas: (1) examination of alterations in blood flow and vessel mechanics caused by coarctation (narrowing) of the aorta and the use of computational modeling to compare surgical and transcatheter methods of treatment, (2) creation of a computational model of the entire pulmonary vascular tree and computational modeling of various disease states including pulmonary artery stenosis and pulmonary hypertension as a disease stratification tool and better predict responses to therapy, and (3) the use of computational modeling to examine flow characteristics and energy efficiency at rest and varying degrees of exercise in patients who have undergone total cavopulmonary connection.
Clinical Trials
- Extension Study to Evaluate the Long Term Safety and Tolerability of Ambrisentan in Children with Pulmonary Hypertension aged 8-17 Recruiting
- Safety and Efficacy Study of Ambrisentan for Treatment of Pulmonary Arterial Hypertension in Children Aged 8-17 Recruiting
- Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension (TOPP) Recruiting
- Management of acute pulmonary hypertensive crisis in children with known pulmonary arterial hypertension Recruiting
Publications
- A method for quantitative characterization of growth in the 3-D structure of rat pulmonary arteries. Microvasc Res. 2012
- Computational fluid dynamic simulations for determination of ventricular workload in aortic arch obstructions. J Thorac Cardiovasc Surg. 2012
- Hypoplastic left heart syndrome: current considerations and expectations. J Am Coll Cardiol. 2012; (1 Suppl): S1-42
- Computational simulations demonstrate altered wall shear stress in aortic coarctation patients treated by resection with end-to-end anastomosis. Congenit Heart Dis. 2011 Sep-Oct; (5): 432-43
- A rapid and computationally inexpensive method to virtually implant current and next-generation stents into subject-specific computational fluid dynamics models. Ann Biomed Eng. 2011; (5): 1423-37
